Towards New Frontiers of Direct Oral Anticoagulants: Sickle Cell Disease

Acta Haematol. 2019;142(4):195-196. doi: 10.1159/000501442. Epub 2019 Jul 17.

Authors

Andrea Boccatonda¹, Francesca Santilli²

Affiliations

¹ Department of Medicine and Aging and Center of Aging Science and Translational Medicine (CESI-Met), G. d'Annunzio University of Chieti, Chieti, Italy, [email protected].
² Department of Medicine and Aging and Center of Aging Science and Translational Medicine (CESI-Met), G. d'Annunzio University of Chieti, Chieti, Italy.

PMID: 31315111
DOI: 10.1159/000501442

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anemia, Sickle Cell*
Anticoagulants
Heparin, Low-Molecular-Weight
Humans
Incidence
Venous Thromboembolism*
Vitamin K

Substances

Anticoagulants
Heparin, Low-Molecular-Weight
Vitamin K